Changping Wu
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 30
- Cancer Immunotherapy and Biomarkers 12
- Colorectal Cancer Treatments and Studies 5
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Jingting Jiang (52 shared papers)Xiao Zheng (14 shared papers)Xueguang Zhang (6 shared papers)Yibei Zhu (5 shared papers)Lujun Chen (17 shared papers)Binfeng Lu (9 shared papers)Ning Xu (4 shared papers)Bin Xu (15 shared papers)
- Journals
- Oncotarget (6 papers)Cellular Physiology and Biochemistry (3 papers)Molecular Cancer (2 papers)International Journal of Hyperthermia (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Changping Wu
77 papers receiving 3.3k citations
Changping Wu's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.3k
- Cancer Research 664
- Immunology 913
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 430
Countries citing papers authored by Changping Wu
This map shows the geographic impact of Changping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changping Wu more than expected).
Fields of papers citing papers by Changping Wu
This network shows the impact of papers produced by Changping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changping Wu. The network helps show where Changping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Changping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling Hit paper breakdown → | 2019 | 437 |
| 2 | 2006 | 435 | |
| 3 | 2014 | 193 | |
| 4 | 2014 | 176 | |
| 5 | N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA Hit paper breakdown → | 2022 | 133 |
| 6 | 2018 | 131 | |
| 7 | 2013 | 124 | |
| 8 | 2014 | 110 | |
| 9 | 2014 | 100 | |
| 10 | 2017 | 96 | |
| 11 | 2010 | 86 | |
| 12 | 2017 | 82 | |
| 13 | 2015 | 79 | |
| 14 | 2020 | 78 | |
| 15 | 2011 | 69 | |
| 16 | 2011 | 60 | |
| 17 | 2007 | 60 | |
| 18 | B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer. | 2015 | 55 |
| 19 | 2013 | 43 | |
| 20 | 2017 | 33 |
About Changping Wu
Changping Wu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Cancer Research, having authored 78 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Immune Cell Function and Interaction (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Immunotherapy and Immune Responses (5 papers), Cancer-related molecular mechanisms research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (664 citations), Immunology (913 citations), Molecular Biology (1.1k citations) and Pulmonary and Respiratory Medicine (430 citations). Changping Wu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jingting Jiang, Xiao Zheng, Xueguang Zhang, Yibei Zhu, Lujun Chen, Binfeng Lu, Ning Xu, Bin Xu, Jiemin Zhao and Qi Wang. Their work appears in journals such as Oncotarget, Cellular Physiology and Biochemistry, Molecular Cancer, International Journal of Hyperthermia and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.